Neuroalojen ja kuntoutuksen vastuualue

Julkaisut 2018 (alustava)
Publications 2018 (preliminary)

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Al-Tahan S et al. Novel valosin-containing protein mutations associated with multisystem proteinopathy.
2 Alanen M et al. Procedural complications of endovascular treatment in patients with aneurysmal subarachnoid haemorrhage treated at a single centre.
3 Alapirtti T. Seizure-related Inflammation in Refractory Epilepsy Patients : A video-EEG study.
4 Alapirtti T et al. The production of IL-6 in acute epileptic seizure: A video-EEG study.
5 Alapirtti T et al. The production of IL-6 in acute epileptic seizure: A video-EEG study.
6 Brockmann S et al. CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency.
7 Caggiano P, Jehkonen M. The 'Neglected' Personal Neglect.
8 Castiglioni C et al. Neuromyopathy with congenital cataracts and glaucoma: a distinct syndrome caused by POLG variants.
9 Erkkilä M et al. Executive Functions and Emotion-Attention Interaction in Assessment of Brain Health: Reliability of Repeated Testing With Executive RT Test and Correlation With BRIEF-A Questionnaire.
10 Genin E et al. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
11 Gormley P et al. Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families.
12 Haapasalo J et al. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
13 Hietaharju A, Finnegrup N. Introduction to the PAIN supplement on neuropathic pain.
14 Himanen SL et al. Prolonged partial obstruction during sleep is a NREM phenomenon.
15 Hänninen T et al. Sport Concussion Assessment Tool: Interpreting day-of-injury scores in professional ice hockey players.
16 Ihalainen T. Incidence, Risk Factors and Recovery of Laryngeal Penetration-Aspiration after Traumatic Cervical Spinal Cord Injury.
17 Ihalainen T et al. Traumatic cervical spinal cord injury: recovery of penetration/aspiration and functional feeding outcome.
18 Ihalainen T et al. Risk factors for laryngeal penetration-aspiration in patients with acute traumatic cervical spinal cord injury.
19 Isokuortti H et al. Characterizing the type and location of intracranial abnormalities in mild traumatic brain injury.
20 Jolma P et al. Oral Dipyridamole-Associated Circulatory Collapse.
21 Jonson PH et al. Novel mutations in DNAJB6 cause LGMD1D and distal myopathy in French families.
22 Järvenpää S et al. Reversible psychiatric adverse effects related to deep brain stimulation of the anterior thalamus in patients with refractory epilepsy.
23 Järvenpää S et al. Executive Functions May Predict Outcome in Deep Brain Stimulation of Anterior Nucleus of Thalamus for Treatment of Refractory Epilepsy.
24 Kiiski H et al. S100B, NSE and MMP-9 fail to predict neurologic outcome while elevated S100B associates with milder initial clinical presentation after aneurysmal subarachnoid hemorrhage.
25 Korhonen VE et al. Copy number loss in SFMBT1 is common among Finnish and Norwegian patients with iNPH.
26 Kulju T et al. Similarities between the responses to ANT-DBS and prior VNS in refractory epilepsy.
27 Kuusinen V et al. Orbitofrontal Lesion Alters Brain Dynamics of Emotion-Attention and Emotion-Cognitive Control Interaction in Humans.
28 Lahti J et al. Cognitive Impairment and Recovery in Meningiomas and Low-Grade Gliomas.
29 Lawthom C et al. Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
30 Lee Y et al. TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations.
31 Lepistö S et al. Healthcare professionals’ work engagement in Finnish university hospitals.
32 Lepistö S et al. Healthcare professionals' work engagement in Finnish university hospitals.
33 Liimatainen S et al. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
34 Liimatainen S et al. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
35 Luoto T et al. Aivovammat.
36 Luoto T et al. Aivovammojen luokittelu.
37 Luoto T et al. Aivovammapotilaan ensihoito.
38 Luoto T et al. Aivovamman hoito vaikeusasteen mukaan.
39 Luoto T et al. Kallonsisäisten hematoomien tyhjennys.
40 Luoto T et al. Kallonmurtumien hoito.
41 Luoto T et al. Aivovamman jatkohoito.
42 Luoto T et al. Aivovammat. Käypä hoito-suosituksen päivitystiivistelmä.
43 Makkonen T. Changes in Speech and Communication in Patients with Amyotrophic Lateral Sclerosis : A two-year follow-up study.
44 Makkonen T et al. Variation in communication strategies in amyotrophic lateral sclerosis during a two-year follow-up.
45 Makkonen T et al. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms.
46 Members OF the Ms in the 21st Century Steering Group et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.
47 Murtonen A et al. Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections.
48 Mäkelä KM et al. Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.
49 Mäkinen J. Epilepsy : More than seizures, optimizing antiepileptic drug therapy.
50 Mäkinen J et al. Discontinuation of carbamazepine due to concerns of long-term consequences of enzyme induction.
51 Niemelä M et al. Neurokirurgia ja neurotautien yksilöllistetty hoito Suomessa.
52 Nora T et al. Stimulation Induced Electrographic Seizures in Deep Brain Stimulation of the Anterior Nucleus of the Thalamus Do Not Preclude a Subsequent Favorable Treatment Response.
53 Nordfors K et al. Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma.
54 Nurmela K et al. Identification of major depressive disorder among the long-term unemployed.
55 Nurmela K et al. Identification of Depression and Screening for Work Disabilities among Long-Term Unemployed People.
56 Nurmi L et al. Occurrence and Recovery of Different Neglect-Related Symptoms in Right Hemisphere Infarct Patients during a 1-Year Follow-Up.
57 Oates E et al. Congenital Titinopathy: Comprehensive characterization and pathogenic insights.
58 Ollikainen J et al. The Finnish Prehospital Stroke Scale Detects Thrombectomy and Thrombolysis Candidates-A Propensity Score-Matched Study.
59 Partinen M et al. Narkolepsian moninainen oirekuva ja käypä diagnostiikka.
60 Peciola S et al. Under-reporting of nocturnal seizures using video-based home monitoring: a case study on the evaluation of the effect of vagal nerve stimulation.
61 Pyysalo M et al. The dental infections in patients undergoing preoperative dental examination before surgical treatment of saccular intracranial aneurysm.
62 Pöytäkangas T et al. Epileptisen kohtauksen tunnistaminen ja ensihoito.
63 Raj R et al. Temporal Trends in Healthcare Costs and Outcome Following ICU Admission After Traumatic Brain Injury.
64 Rosti-Otajärvi E, Hämäläinen P. MS-tautia sairastavan kognitiiviseen toimintakykyyn tulisi kiinnittää huomiota jo varhain.
65 Sainio M et al. Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy.
66 Sarkanen T et al. Narcolepsy Associated with Pandemrix Vaccine.
67 Savarese M et al. The complexity of titin splicing pattern in human adult skeletal muscles.
68 Savarese M et al. Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.
69 Savarese M et al. Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease.
70 Sellier C et al. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
71 Sillanpää N et al. Chronic Infarcts Predict Poor Clinical Outcome in Mechanical Thrombectomy of Sexagenarian and Older Patients.
72 Sorri A et al. Low tumor necrosis factor-a levels predict symptom reduction during electroconvulsive therapy in major depressive disorder.
73 Sorri A et al. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
74 Sumelahti M et al. Painful musculosceletal disorders and depression among working aged migraineurs.
75 Sumowski J et al. Cognition in multiple sclerosis: State of the field and priorities for the future.
76 Suokas K et al. Pain in SCN4A Mutated P.A1156T muscle sodium channelopathy-a postal survey.
77 Tasca G et al. MRI in sarcoglycanopathies: a large international cohort study.
78 Tasca G, Udd B. Hereditary myopathy with early respiratory failure (HMERF): Still rare, but common enough.
79 Thesleff T et al. Preventable diagnostic errors in fatal cervical spine injuries: a nationwide register-based study from 1987 to 2010.
80 Vihola A et al. Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy.
Julkaisutietokanta 31.12.2019 Publications Data Base 31.12.2019